Galectin Therapeutics Statistics
Total Valuation
GALT has a market cap or net worth of $176.67 million. The enterprise value is $256.42 million.
Important Dates
The last earnings date was Wednesday, November 13, 2024, before market open.
Earnings Date | Nov 13, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
GALT has 62.76 million shares outstanding. The number of shares has increased by 4.27% in one year.
Current Share Class | 62.76M |
Shares Outstanding | 62.76M |
Shares Change (YoY) | +4.27% |
Shares Change (QoQ) | +0.07% |
Owned by Insiders (%) | 20.30% |
Owned by Institutions (%) | 15.68% |
Float | 43.59M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.13
Current Ratio | 1.13 |
Quick Ratio | 1.07 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -8.49 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -96.72% |
Return on Capital (ROIC) | -207.88% |
Revenue Per Employee | n/a |
Profits Per Employee | -$3.23M |
Employee Count | 14 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +43.62% in the last 52 weeks. The beta is 0.63, so GALT's price volatility has been lower than the market average.
Beta (5Y) | 0.63 |
52-Week Price Change | +43.62% |
50-Day Moving Average | 2.69 |
200-Day Moving Average | 2.60 |
Relative Strength Index (RSI) | 55.36 |
Average Volume (20 Days) | 152,705 |
Short Selling Information
The latest short interest is 5.52 million, so 8.79% of the outstanding shares have been sold short.
Short Interest | 5.52M |
Short Previous Month | 5.46M |
Short % of Shares Out | 8.79% |
Short % of Float | 12.66% |
Short Ratio (days to cover) | 42.37 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -39.57M |
Pretax Income | -44.65M |
Net Income | -45.23M |
EBITDA | n/a |
EBIT | -39.57M |
Earnings Per Share (EPS) | -$0.73 |
Full Income Statement Balance Sheet
The company has $27.06 million in cash and $104.59 million in debt, giving a net cash position of -$77.53 million or -$1.24 per share.
Cash & Cash Equivalents | 27.06M |
Total Debt | 104.59M |
Net Cash | -77.53M |
Net Cash Per Share | -$1.24 |
Equity (Book Value) | -92.48M |
Book Value Per Share | -1.52 |
Working Capital | 3.41M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -33.68M |
Capital Expenditures | n/a |
Free Cash Flow | -33.68M |
FCF Per Share | -$0.54 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
GALT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -4.27% |
Shareholder Yield | -4.27% |
Earnings Yield | -25.60% |
FCF Yield | -19.06% |
Analyst Forecast
The average price target for GALT is $11.00, which is 290.76% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $11.00 |
Price Target Difference | 290.76% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on March 23, 2012. It was a reverse split with a ratio of 0.1666666:1.
Last Split Date | Mar 23, 2012 |
Split Type | Reverse |
Split Ratio | 0.1666666:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |